These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27631193)

  • 1. SLCO1B1 Gene Variations Among Tanzanians, Ethiopians, and Europeans: Relevance for African and Worldwide Precision Medicine.
    Aklillu E; Habtewold A; Ngaimisi E; Yimer G; Mugusi S; Amogne W; Reuter T; Meid A; Hoffmann MM; Weiss J
    OMICS; 2016 Sep; 20(9):538-45. PubMed ID: 27631193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population.
    Pasanen MK; Backman JT; Neuvonen PJ; Niemi M
    Eur J Clin Pharmacol; 2006 Jun; 62(6):409-15. PubMed ID: 16758257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of the SLCO1B1 388A>G and the 521T>C polymorphism in Tanzania genotyped by a new LightCycler®-based method.
    Aklillu E; Mugusi S; Ngaimisi E; Hoffmann MM; König S; Ziesenitz V; Mikus G; Haefeli WE; Weiss J
    Eur J Clin Pharmacol; 2011 Nov; 67(11):1139-45. PubMed ID: 21630030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping SLCO1B1 Genetic Variation for Global Precision Medicine in Understudied Regions in Africa: A Focus on Zulu and Cape Admixed Populations.
    Hoosain N; Pearce B; Jacobs C; Benjeddou M
    OMICS; 2016 Sep; 20(9):546-54. PubMed ID: 27631194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global analysis of genetic variation in SLCO1B1.
    Pasanen MK; Neuvonen PJ; Niemi M
    Pharmacogenomics; 2008 Jan; 9(1):19-33. PubMed ID: 18154446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa populations.
    Ngaimisi E; Habtewold A; Minzi O; Makonnen E; Mugusi S; Amogne W; Yimer G; Riedel KD; Janabi M; Aderaye G; Mugusi F; Bertilsson L; Aklillu E; Burhenne J
    PLoS One; 2013; 8(7):e67946. PubMed ID: 23861838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked differences in frequencies of statin therapy relevant SLCO1B1 variants and haplotypes between Roma and Hungarian populations.
    Nagy A; Sipeky C; Szalai R; Melegh BI; Matyas P; Ganczer A; Toth K; Melegh B
    BMC Genet; 2015 Sep; 16():108. PubMed ID: 26334733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of SLCO1B1 sequence variability among German, Turkish, and African populations.
    Mwinyi J; Köpke K; Schaefer M; Roots I; Gerloff T
    Eur J Clin Pharmacol; 2008 Mar; 64(3):257-66. PubMed ID: 18185926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of functional exonic single-nucleotide polymorphisms and haplotype distribution in the SLCO1B1 gene across genetic ancestry groups in the Qatari population.
    Dashti M; Al-Matrouk A; Channanath A; Al-Mulla F; Thanaraj TA
    Sci Rep; 2022 Sep; 12(1):14858. PubMed ID: 36050458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians.
    Sortica Vde A; Ojopi EB; Genro JP; Callegari-Jacques S; Ribeiro-Dos-Santos A; de Moraes MO; Romano-Silva MA; Pena SD; Suarez-Kurtz G; Hutz MH
    Basic Clin Pharmacol Toxicol; 2012 May; 110(5):460-8. PubMed ID: 22136368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of single nucleotide polymorphisms and haplotypes of the SLCO1B1 gene on the pharmacokinetic profile of atorvastatin in healthy Macedonian volunteers.
    Daka A; Dimovski A; Kapedanovska A; Vavlukis M; Eftimov A; Labachevski N; Jakjovski K; Geshkovska MN; Nebija D; Mladenovska K
    Pharmazie; 2015 Jul; 70(7):480-8. PubMed ID: 26373210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organic anion transporting polypeptide-1B1 haplotypes in Chinese patients.
    Xu LY; He YJ; Zhang W; Deng S; Li Q; Zhang WX; Liu ZQ; Wang D; Huang YF; Zhou HH; Sun ZQ
    Acta Pharmacol Sin; 2007 Oct; 28(10):1693-7. PubMed ID: 17883959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frequency of major
    Alrajeh K; AlAzzeh O; Roman Y
    Pharmacogenomics; 2023 May; 24(7):381-398. PubMed ID: 37222158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure.
    Endo S; Fukahori A; Tokuhiro S; Shinagawa A; Walker J; Yoshihara K; Ishizuka H; Ieiri I; Sugiyama Y
    J Hum Genet; 2012 Aug; 57(8):531-44. PubMed ID: 22695893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLCO1B1 gene variability influences lipid-lowering efficacy on simvastatin therapy in Southern Brazilians.
    Sortica VA; Fiegenbaum M; Lima LO; Van der Sand CR; Van der Sand LC; Ferreira ME; Pires RC; Hutz MH
    Clin Chem Lab Med; 2012 Mar; 50(3):441-8. PubMed ID: 22505549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organic anion transporting polypeptide 1B1 (OATP1B1) and OATP1B3: genetic variability and haplotype analysis in white Canadians.
    Boivin AA; Cardinal H; Barama A; Pichette V; Hébert MJ; Roger M
    Drug Metab Pharmacokinet; 2010; 25(5):508-15. PubMed ID: 20877131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLCO1B1 polymorphism and oral antidiabetic drugs.
    Kalliokoski A; Neuvonen PJ; Niemi M
    Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):775-81. PubMed ID: 20406215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response.
    Rodrigues AC; Perin PM; Purim SG; Silbiger VN; Genvigir FD; Willrich MA; Arazi SS; Luchessi AD; Hirata MH; Bernik MM; Dorea EL; Santos C; Faludi AA; Bertolami MC; Salas A; Freire A; Lareu MV; Phillips C; Porras-Hurtado L; Fondevila M; Carracedo A; Hirata RD
    Int J Mol Sci; 2011; 12(9):5815-27. PubMed ID: 22016628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No impact of SLCO1B1 521T>C, 388A>G and 411G>A polymorphisms on response to statin therapy in the Greek population.
    Giannakopoulou E; Ragia G; Kolovou V; Tavridou A; Tselepis AD; Elisaf M; Kolovou G; Manolopoulos VG
    Mol Biol Rep; 2014 Jul; 41(7):4631-8. PubMed ID: 24668570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of SLCO1B1: haplotypes, htSNPs and hepatic expression in three distinct Asian populations.
    Jada SR; Xiaochen S; Yan LY; Xiaoqiang X; Lal S; Zhou SF; Ooi LL; Chowbay B
    Eur J Clin Pharmacol; 2007 Jun; 63(6):555-63. PubMed ID: 17415554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.